CORREVIO PHARMA CORP's ticker is CORV and the CUSIP is 22026V105. A total of 27 filers reported holding CORREVIO PHARMA CORP in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $39,000 | +290.0% | 101,391 | +322.4% | 0.00% | – |
| Q4 2019 | $10,000 | +900.0% | 24,006 | +3901.0% | 0.00% | – |
| Q3 2019 | $1,000 | -50.0% | 600 | -40.5% | 0.00% | – |
| Q2 2019 | $2,000 | 0.0% | 1,009 | +68.2% | 0.00% | – |
| Q1 2019 | $2,000 | +100.0% | 600 | 0.0% | 0.00% | – |
| Q4 2018 | $1,000 | -95.2% | 600 | -88.9% | 0.00% | – |
| Q3 2018 | $21,000 | +950.0% | 5,415 | +802.5% | 0.00% | – |
| Q2 2018 | $2,000 | – | 600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|